{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:12:55Z","timestamp":1792807975753,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:p>\n            The role of salt restriction in patients with impaired glucose tolerance and diabetes mellitus is controversial, with a lack of well controlled, longer term, modest salt reduction trials in this group of patients, in spite of the marked increase in cardiovascular risk. We carried out a 12-week randomized double-blind, crossover trial of salt restriction with salt or placebo tablets, each for 6 weeks, in 46 individuals with diet-controlled type 2 diabetes mellitus or impaired glucose tolerance and untreated normal or high normal blood pressure (BP). From salt to placebo, 24-hour urinary sodium was reduced by 49\u00b19 mmol (2.9 g salt). This reduction in salt intake led to fall in clinic BP from 136\/81\u00b12\/1 mm Hg to 131\/80\u00b12\/1 mm Hg, (systolic BP;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01). Mean ambulatory 24-hour BP was reduced by 3\/2\u00b11\/1 mm Hg (systolic BP,\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01 and diastolic BP,\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05), and albumin\/creatinine ratio was reduced from 0.73 mg\/mmol (0.5\u20131.5) to 0.64 mg\/mmol (0.3\u20131.1;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05). There was no significant change in fasting glucose, hemoglobin A1c, or insulin sensitivity. These results demonstrate that a modest reduction in salt intake, to approximately the amount recommended in public health guidelines, leads to significant and clinically relevant falls in BP in individuals who are early on in the progression of diabetes mellitus with normal or mildly raised BP. The reduction in urinary albumin excretion may carry additional benefits in reducing cardiovascular disease above the effects on BP.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.115.06637","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T04:25:45Z","timestamp":1462854345000},"page":"1189-1195","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["Modest Salt Reduction Lowers Blood Pressure and Albumin Excretion in Impaired Glucose Tolerance and Type 2 Diabetes Mellitus"],"prefix":"10.1161","volume":"67","author":[{"given":"Rebecca J.","family":"Suckling","sequence":"first","affiliation":[{"name":"From the South West Thames Renal and Transplantation Unit, Epsom and St. Helier Hospital, London, United Kingdom (R.J.S.); and Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (F.J.H., N.D.M., G.A.M.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng J.","family":"He","sequence":"additional","affiliation":[{"name":"From the South West Thames Renal and Transplantation Unit, Epsom and St. Helier Hospital, London, United Kingdom (R.J.S.); and Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (F.J.H., N.D.M., G.A.M.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala D.","family":"Markandu","sequence":"additional","affiliation":[{"name":"From the South West Thames Renal and Transplantation Unit, Epsom and St. Helier Hospital, London, United Kingdom (R.J.S.); and Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (F.J.H., N.D.M., G.A.M.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.","family":"MacGregor","sequence":"additional","affiliation":[{"name":"From the South West Thames Renal and Transplantation Unit, Epsom and St. Helier Hospital, London, United Kingdom (R.J.S.); and Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (F.J.H., N.D.M., G.A.M.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.412"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2009.12.006"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1325"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006763.pub2"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.133223"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000114022.20424.22"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.6.1220"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.2.444"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2008.26856"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.24.711"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1487"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.26.3.485"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00441-6"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/hq0102.101770"},{"key":"e_1_3_4_16_2","unstructured":"Doulton TWR. The influence of sodium on cardiovascular risk factors in chronic kidney disease. London United Kingdom: St. George\u2019s University of London; 2007."},{"key":"e_1_3_4_17_2","volume-title":"Scientific Advisory Committee on Nutrition, Salt and Health Report","author":"Public Health England","year":"2003","unstructured":"Public Health England. Scientific Advisory Committee on Nutrition, Salt and Health Report. 2003. www.gov.uk\/government\/publications\/sacn-salt-and-health-report. Accessed February 2, 2016."},{"key":"e_1_3_4_18_2","volume-title":"The World Health Report 2002 - Reducing Risks, Promoting Healthy Life. World Health Organisation Website","author":"World Health Organisation","unstructured":"World Health Organisation. The World Health Report 2002 - Reducing Risks, Promoting Healthy Life. World Health Organisation Website. http:\/\/www.who.int\/whr\/2002\/en\/. Accessed February 2, 2016."},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00653.x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.10.019"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.538132"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133312.96477.48"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01390.x"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000172662.12480.7f"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.210"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)01310-3"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.5.4835"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.155747"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61174-4"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1723"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.490"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2008.144"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.5.1047"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.115.06637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:54:06Z","timestamp":1715594046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.115.06637"}},"subtitle":["A Randomized Double-Blind Trial"],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.115.06637"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.115.06637","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"2015-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}